Fraser Craig's Form 4 filing
Windtree Therapeutics Inc (WINT) · filed Apr 26, 2023
- Accession no.
- 0001437749-23-011064
- Filed
- Apr 26, 2023
- Trade date
- Apr 25, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.49K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fraser CraigCIK 0001557420 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2023 | Common Stock | PPurchaseAcquired | +1,315 | $1.89 | +$2,485.35 | 5,513 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.